Clayton, MO, United States of America

James J Havranek

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Washington University. Active years: 2016-2025.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 61(Granted Patents)


Location History:

  • St. Louis, MO (US) (2018)
  • Clayton, MO (US) (2016 - 2020)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: James J Havranek: Innovator in Polypeptide Analysis

Introduction

James J Havranek is a notable inventor based in Clayton, MO (US). He has made significant contributions to the field of polypeptide analysis and processing. With a total of 4 patents, his work focuses on advancing methods for protein analysis and site-specific recombination.

Latest Patents

Havranek's latest patents include innovative methods and reagents for the digital analysis of proteins or peptides. One of his key inventions involves proteins that identify the N-terminal amino acid or N-terminal phosphorylated amino acid of a polypeptide. Additionally, he has developed an enzyme for use in the cleavage step of the Edman degradation reaction, along with a method for utilizing this enzyme. Another significant patent relates to enzymes, compositions, and methods for catalyzing site-specific recombination at asymmetric sites.

Career Highlights

James J Havranek is affiliated with Washington University, where he continues to contribute to research and innovation in his field. His work has implications for various applications in biochemistry and molecular biology.

Collaborations

Havranek has collaborated with notable colleagues, including Benjamin Borgo and Chi Zhang, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

James J Havranek's contributions to polypeptide analysis and processing highlight his role as an innovator in the scientific community. His patents reflect a commitment to advancing methodologies that can significantly impact research and applications in biochemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…